TSLP Antibody FITC

General Information

Product

TSLP Antibody FITC

Description

FITC-Conjugated Thymic Stromal LymphoPoietin Antibody

Verified Applications

ELISA, IP, WB

Host

Rabbit

Species Cross Reactivity

Human

Immunogen

Synthetic peptide taken within amino acid region 50-100 on human Thymic Stromal LymphoPoietin.

Physical Properties

Quantity

100 µg

Volume

200 µl

Concentration

0.5-1.5 µg/µl in antibody stabilization buffer

Immunoglobulin

IgG

Form

FITC-Conjugated

Purification Method

Immobilized antigen affinity chromatography

Clonality

Polyclonal

Storage

-20⁰C for long term storage

Application Protocol

ELISA

1:50,000

Immunoprecipitation

1:200

Western Blot

1:500-1:5,000

Protein

Uniprot #

Q969D9

Molecular Function

cytokine activity

interleukin-7 receptor binding

Subcellular Location

Extracellular region or secreted

Expression

Isoform 1 is expressed in a number of tissues including heart, liver and prostate. Isoform 2 is the predominant form in keratinocytes of oral mucosa, skin and in salivary glands. It is secreted into saliva.

Structure

Interacts with a receptor composed of CRLF2 and IL7R. Binding of TSLP to CRLF2/TSLPR is a mechanistic prerequisite for recruitment of IL7R to the high-affinity ternary complex.

Alternative Nomenclature

Thymic stromal lymphopoietin antibody

Thymic stromal lymphopoietin protein TSLP antibody

Tslp antibody

TSLP protein antibody

TSLP_HUMAN antibody